Health Business

TAKE Solutions reports continued strong growth in Life Sciences segment

18% Y-o-Y growth in revenue & 9.4 % in profit

Particulars Figures in FY18 Q4 FY18 FY17  Q4 FY17 Change (%)
Revenue INR Mn 15,872 4,539 13,446 3,555 18.0%
USD Mn 246 70 200 53  
Op. EBITDA INR Mn 3,065 905 2,622 690 16.9%
Margin % 19.3% 19.9% 19.5% 19.4%  
Net Profit INR Mn 1,599 455 1,462 418 9.4%
Margin % 10.0% 10.0% 10.8% 11.7%  
EPS INR 12.19 3.45 11.22 3.13 8.6%

 TAKE Solutions Ltd. [BSE: 532890 | NSE: TAKE], a globally recognized domain intensive services provider in Life Sciences, today announced its financial results for Q4 and year ended FY18. The company reported FY18 revenues of INR Mn 15,872 a 18% growth over the previous year.


Key highlights over the year:

  • Strong growth in Life Sciences 30.3% Y-o-Y and 8.37% CQGR over last 12 quarters
  • Flagship product pharmaReady has surpassesd its milestone of 150 customers
  • Recognized as

o   A ‘Leader’ in the IDC MarketScape: Worldwide Life Science Drug Safety Services 2017 Vendor Assessment

o   ‘Best Employer Brand’ for the second consecutive year and ranked 3rd in the ‘Times Ascent presents Dream Companies to Work For’ category at the World HRD Congress

Srinivasan H R, Vice Chairman and Managing Director, TAKE Solutions said, “Financial year 2018 has been a positive year for TAKE Solutions with continued strong performance in life sciences business in terms of profitability, customer track record and recognition. Looking ahead, we have a healthy pipeline of new business opportunities in India and we plan to carry this momentum through the year. We are keen to pursue strategic acquisitions in North America and Europe, funded by our recent preferential allotment of shares, to capitalize on our opportunities and scale our business in the high-growth Clinical and Regulatory spaces.”

For more information on our earnings release, 

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

To Top